Skip to main content
BiotoxtechCo.,Ltd. logo

BiotoxtechCo.,Ltd. — Investor Relations & Filings

Ticker · 086040 ISIN · KR7086040003 KO Professional, scientific and technical activities
Open in API
Filings indexed 172 across all filing types
Latest filing 2024-12-06 Major Shareholding Noti…
Country KR South Korea
Listing KO 086040

About BiotoxtechCo.,Ltd.

http://eng.biotoxtech.com/

Biotoxtech Co., Ltd. is a non-clinical Contract Research Organization (CRO) that provides safety and efficacy evaluation services. The company offers a comprehensive suite of GLP-compliant studies, including general toxicity, carcinogenicity, reproductive and developmental toxicity, genotoxicity, immunotoxicity, and safety pharmacology. It also conducts efficacy evaluations and provides analytical research services such as pharmacokinetics (PK/TK/ADME) and bioanalysis. Biotoxtech serves a diverse clientele developing pharmaceuticals, biomedicines, cell and gene therapies, medical devices, chemicals, agrochemicals, cosmetics, and health functional foods.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Financial Investment Services and Capital Markets Act. It details changes in share ownership by major shareholders and their special related parties, including specific transaction dates, methods (e.g., open market purchases), and the purpose of holding (e.g., influencing management). This fits the definition of a Major Shareholding Notification.
2024-12-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Kang Jong-koo) and related parties in the company 'Biotoxtech'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes.
2024-12-05 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from Biotoxtech regarding the 'Acquisition of Convertible Bonds before Maturity'. It details the specific terms of the bond, the acquisition amount, the reason for acquisition (early redemption request by the bondholder), and the method of cancellation. This falls under capital structure and financing updates, specifically related to debt instruments, which is classified as CAP (Capital/Financing Update).
2024-11-25 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details the change in shareholding (specifically the early redemption of convertible bonds) by an asset management firm (에스피자산운용(주)) in a listed company (바이오톡스텍). This type of filing is a standard regulatory requirement for significant ownership changes, which falls under the 'Major Shareholding Notification' category.
2024-11-25 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for Biotoxtech Co., Ltd. for the third quarter of 2024. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 1% confidence The document is a 'Report on Acquisition Status by Trust Contract' (신탁계약등에의한취득상황보고서) filed by Biotoxtech Co., Ltd. to the Financial Supervisory Service (FSS). It details the company's share buyback activity through a trust agreement with Eugene Investment & Securities. This type of filing specifically reports the company's transactions in its own shares (share repurchases). According to the provided definitions, 'Transaction in Own Shares' (POS) is the correct category for reports regarding a company buying back its own shares.
2024-10-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.